Key result
Clinical pharmacology and evidence-based practice optimize long-term drug efficacy for cardiometabolic diseases.
Why the study?
Clinical pharmacology plays a crucial role in optimizing drug use and integrating drug therapy into long-term care of cardiovascular diseases, but its comprehensive impact requires synthesis.
Clinical pharmacology plays a crucial role in optimizing the efficacy and efficiency of drug use in cardiovascular and metabolic diseases.
Should not yet change prescribing; leaves open need for prospective trials quantifying benefits in CV-metabolic care.
Clinical pharmacology contributes to many stages of drug development including discovery, registration, and application in clinical practice. The clinical pharmacologists working in academia, in industries, and with government agencies play an important role in optimizing efficacy and efficiency of drug use. The integration of drug therapy into overall long-term clinical care offers further possibilities. For example, long-term care of cardiovascular and metabolic diseases including hypertension and heart failure have been improved by clinical pharmacologists applying evidence-based practice and rational treatment choices.
No takes yet. Share an insight, caveat, or question.
John L. Reid (2003) conducted a review in Cardiovascular and metabolic diseases. Clinical pharmacology and evidence-based practice play an important role in optimizing the efficacy and efficiency of drug use for the long-term care of cardiovascular and metabolic diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: